U.S. flag

An official website of the United States government

NM_001114753.3(ENG):c.1586G>A (p.Arg529His) AND Telangiectasia, hereditary hemorrhagic, type 1

Germline classification:
Pathogenic (3 submissions)
Last evaluated:
Sep 11, 2024
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000229345.10

Allele description [Variation Report for NM_001114753.3(ENG):c.1586G>A (p.Arg529His)]

NM_001114753.3(ENG):c.1586G>A (p.Arg529His)

Genes:
ENG:endoglin [Gene - OMIM - HGNC]
LOC102723566:uncharacterized LOC102723566 [Gene]
Variant type:
single nucleotide variant
Cytogenetic location:
9q34.11
Genomic location:
Preferred name:
NM_001114753.3(ENG):c.1586G>A (p.Arg529His)
Other names:
p.R529H:CGC>CAC; NM_001114753.3(ENG):c.1586G>A
HGVS:
  • NC_000009.12:g.127818220C>T
  • NG_009551.1:g.41549G>A
  • NM_000118.4:c.1586G>A
  • NM_001114753.3:c.1586G>AMANE SELECT
  • NM_001278138.2:c.1040G>A
  • NP_000109.1:p.Arg529His
  • NP_000109.1:p.Arg529His
  • NP_001108225.1:p.Arg529His
  • NP_001108225.1:p.Arg529His
  • NP_001265067.1:p.Arg347His
  • LRG_589t1:c.1586G>A
  • LRG_589t2:c.1586G>A
  • LRG_589:g.41549G>A
  • LRG_589p1:p.Arg529His
  • LRG_589p2:p.Arg529His
  • NC_000009.11:g.130580499C>T
  • NM_000118.2:c.1586G>A
  • NM_000118.3:c.1586G>A
  • NM_001114753.1:c.1586G>A
  • NM_001114753.2:c.1586G>A
  • P17813:p.Arg529His
  • p.(Arg529His)
Protein change:
R347H
Links:
UniProtKB: P17813#VAR_070299; dbSNP: rs863223538
NCBI 1000 Genomes Browser:
rs863223538
Molecular consequence:
  • NM_000118.4:c.1586G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001114753.3:c.1586G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001278138.2:c.1040G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Telangiectasia, hereditary hemorrhagic, type 1 (HHT1)
Synonyms:
Osler Weber Rendu syndrome type 1
Identifiers:
MONDO: MONDO:0008535; MedGen: C4551861; Orphanet: 774; OMIM: 187300

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000590887Center of Genomic medicine, Geneva, University Hospital of Geneva
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(May 16, 2017)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV003799021Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Dec 9, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV005326488ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel, ClinGen
reviewed by expert panel

(ClinGen HHT ACMG Specifications ENG V1.1.0)
Pathogenic
(Sep 11, 2024)
germlinecuration

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Center of Genomic medicine, Geneva, University Hospital of Geneva, SCV000590887.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center, SCV003799021.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

PS3, PM1, PM2

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel, ClinGen, SCV005326488.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The NM_001114753.3: c.1586G>A variant in ENG is a missense variant predicted to cause substitution of arginine by histidine at amino acid 529 (p.Arg529His). This variant has been reported in more than 10 probands with a phenotype consistent with HHT (PS4; PMID: 22991266, 16752392, Internal lab contributors). At least one patient's phenotype meets Curacao Criteria for HHT, and sequencing and large deletion/duplication analysis was performed for ENG and ACVRL1, which is highly specific for HHT (PP4_Moderate; Internal lab contributors). The variant has been reported to segregate with HHT in more than 20 affected family members from multiple families (PP1_Strong; Internal lab contributors). The overall minor allele frequency in gnomAD v2.1.1 is 0.000004 (1/251282 alleles), which is lower than the ClinGen Hereditary Hemorrhagic Telangiectasia VCEP threshold (<6 total alleles) for PM2_Supporting, meeting this criterion (PM2_Supporting). The computational predictor REVEL gives a score of 0.579, which is neither above nor below the thresholds predicting a damaging or benign impact on ENG function. In summary, this variant meets the criteria to be classified as pathogenic for autosomal dominant hereditary hemorrhagic telangiectasia based on the ACMG/AMP criteria applied, as specified by the ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel: PM2_Supporting, PS4, PP4_Moderate, PP1_Strong (specifications version 1.1.0; 09/11/2024).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jan 13, 2025